Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $102,984 | $122,873 | $190,169 | $149,191 |
| Dep. & Amort. | $254,024 | $144,733 | $68,252 | $69,867 |
| Deferred Tax | -$125,902 | -$57,789 | -$22,223 | -$17,615 |
| Stock-Based Comp. | $54,191 | $52,742 | $32,810 | $30,586 |
| Change in WC | -$97,554 | -$116,598 | -$105,262 | -$17,252 |
| Other Non-Cash | $332,895 | $97,538 | $14,722 | $61,497 |
| Operating Cash Flow | $520,638 | $243,499 | $178,468 | $276,274 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$115,429 | -$78,274 | -$74,047 | -$56,898 |
| Net Acquisitions | -$17,635 | -$296,028 | -$31,435 | -$34,488 |
| Inv. Purchases | -$113,504 | -$100,643 | -$419,534 | -$622,359 |
| Inv. Sales/Matur. | $70,517 | $777,913 | $414,654 | $337,806 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$176,051 | $302,968 | -$110,362 | -$375,939 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$85,787 | -$225,562 | -$144,493 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $58,091 | -$6,259 | $34,531 | $54,147 |
| Financing Cash Flow | -$27,696 | -$231,821 | -$109,962 | $54,147 |
| Forex Effect | $255 | $2,180 | -$747 | -$810 |
| Net Chg. in Cash | $317,146 | $316,826 | -$42,603 | -$46,328 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $467,292 | $150,466 | $193,069 | $239,397 |
| End Cash | $784,438 | $467,292 | $150,466 | $193,069 |
| Free Cash Flow | $405,209 | $165,225 | $104,421 | $219,376 |